SCHEMBL5319112

SCHEMBL5319112

O=C(O)C1Cc2ccccc2C(Cc2ccccc2)N1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 1/20 0.50
PRCP P42785 1/20 0.50
MAPT P10636 2/20 0.46
GAA P10253 1/20 0.46
CACNA1G O43497 4/20 0.42
KDM4E B2RXH2 2/20 0.40
HIF1A Q16665 1/20 0.40
ADRB2 P07550 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM1A O60341 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
CYP2D6 P10635 1/20 0.38
HDAC8 Q9BY41 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9631444 0.84 MAPT (0.47) MAPTGAAKDM4EHIF1ASMN1; SMN2
SCHEMBL10505998 0.84 MAPT (0.47) PRCPMAPTGAAKDM4ESMN1; SMN2
SCHEMBL17725672 0.83 ADRB2 (0.56) GAACACNA1GADRB2KDM1AMEN1
SCHEMBL17713985 0.83 ADRB2 (0.56) GAACACNA1GADRB2KDM1AMEN1
SCHEMBL28787105 0.76 MAPT (0.53) MAPTGAAKDM4ESMN1; SMN2CYP2D6
SCHEMBL31650932 0.76 MAPT (0.53) MAPTGAAKDM4ESMN1; SMN2CYP2D6
SCHEMBL27398624 0.76 MAPT (0.53) MAPTGAAKDM4ESMN1; SMN2CYP2D6
SCHEMBL268492 0.76 MAPT (0.53) MAPTGAAKDM4ESMN1; SMN2CYP2D6
SCHEMBL29430156 0.76 MAPT (0.53) MAPTGAAKDM4ESMN1; SMN2CYP2D6
SCHEMBL3249767 0.76 CYP2D6 (0.41) MAPTGAAKDM4EHIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1703221-A 2-alkyl- (2-amino-3-aryl-propionyl) -piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity PROCTER & GAMBLE (US) 2005-11-30 CN claimed
WO-2007082666-A1 ACYLAMINOIMIDAZOLES BAYER HEALTHCARE AG (DE) 2007-07-26 WO disclosed
CN-1703221-A 2-alkyl- (2-amino-3-aryl-propionyl) -piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity PROCTER & GAMBLE (US) 2005-11-30 CN disclosed
US-5359074-A Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors HOECHST AKTIENGESELLSCHAFT (DE) 1994-10-25 US disclosed
US-5252738-A Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors HOECHST AKTIENGESELLSCHAFT (DE) 1993-10-12 US disclosed